Alpha 2.0
Login Register
» Articles » PMID: 24397598

Absence of BRAF and KRAS Hotspot Mutations in Primary Mediastinal B-cell Lymphoma

Overview
Journal Leuk Lymphoma
Specialties Hematology
Oncology
Date 2014 Jan 9
PMID 24397598
Citations 4
Authors
Philipp D Nagel
Fenja M Feld
Stephanie E Weissinger
Albrecht Stenzinger
Peter Moller
Jochen K Lennerz
Affiliations
Soon will be listed here.
Citing Articles

An interpretable survival model for diffuse large B-cell lymphoma patients using a biologically informed visible neural network.

Tan J, Xie J, Huang J, Deng W, Chai H, Yang Y Comput Struct Biotechnol J. 2024; 24:523-532.

PMID: 39211335 PMC: 11357880. DOI: 10.1016/j.csbj.2024.07.019.

GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma.

Feld F, Nagel P, Weissinger S, Welke C, Stenzinger A, Moller P Oncotarget. 2015; 6(6):4516-26.

PMID: 25595905 PMC: 4414208. DOI: 10.18632/oncotarget.2799.

KIT mutations in primary mediastinal B-cell lymphoma.

Nagel P, Stenzinger A, Feld F, Herrmann M, Bruderlein S, Barth T Blood Cancer J. 2014; 4:e241.

PMID: 25148223 PMC: 4219474. DOI: 10.1038/bcj.2014.61.

Potential clinical implications of BRAF mutations in histiocytic proliferations.

Bubolz A, Weissinger S, Stenzinger A, Arndt A, Steinestel K, Bruderlein S Oncotarget. 2014; 5(12):4060-70.

PMID: 24938183 PMC: 4147306. DOI: 10.18632/oncotarget.2061.